Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Congratulations to two of GRACE's current Patient Education Ambassadors for their recent awards!
Dr. Medhavi Gupta has received the ASCO GI21 Conquer Cancer Foundation Merit Award.
Dr. Gupta is currently a Hematology-Oncology fellow at Roswell Park Comprehensive Cancer Center in Buffalo, New York. The ASCO GI21 Merit Award recognizes oncology fellows and trainees who are first authors on top-ranking abstracts selected for presentation at the virtual Gastrointestinal Cancers Symposium, 2021. To read more about Dr. Gupta's study, visit https://meetinglibrary.asco.org/record/194118/abstract. For information on the ASCO GI21 Award, please see https://www.conquer.org/news/conquer-cancer-announces-2021-gastrointest….
Dr. Ivy Franco is the inaugural recipient of the Brigham Womens and Dana Farber Diversity Equity Inclusion Award.
Dr. Idalid “Ivy” Franco is a radiation oncology resident at the Harvard Radiation Oncology Program, in Boston, Massachusetts. She is the inaugural recipient of the Diversity Equity Inclusion Award with Dana-Farber/Brigham and Women's Cancer Center, awarded for her outstanding contributions towards efforts at diversity, equity and inclusion within the organization and related to the community at large.
Huge congratulations to these two rising stars! GRACE is honored to work along side of you!
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…